Abstract
Hemophilia A is the most common X-linked bleeding disorder, occurring in approximately 1 in 5000 males across all races and ethnicities. A congenital deficiency or absence of coagulation factor VIII leaves these patients prone to excessive and prolonged bleeding, especially joint and muscle hemorrhages as well as postsurgical, oral, and soft tissue bleeding. Recurrent bleeding into joints leads to chronic arthropathy. Replacement of the deficient factor VIII with plasma-derived or recombinant factor concentrates is the cornerstone of management. Dosing and frequency are determined by the desired plasma factor level, clinical response, and product characteristics.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Mannucci PM, Tuddenham EG. The hemophilias–from royal genes to gene therapy.[see comment][erratum appears in N Engl J Med. 2001;345(5):384]. [Review] [64 refs]. N Engl J Med 2001;344(23):1773–9.
Kulkarni R, Soucie JM, Lusher J, Presley R, Shapiro A, Gill J, et al. Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from the Centers for Disease Control and Prevention’s (CDC) Universal Data Collection (UDC) project. Haemophilia. 2009;15(6):1281–90.
Mansouritorghabeh H, Banihashem A, Modaresi A, Manavifar L. Circumcision in males with bleeding disorders. Mediterr J Hematol Infect Dis. 2013;5(1):e2013004.
Rodriguez V, Titapiwatanakun R, Moir C, Schmidt KA, Pruthi RK. To circumcise or not to circumcise? Circumcision in patients with bleeding disorders. Haemophilia. 2010;16(2):272–6.
Lakich D, Kazazian HH, Antonarakis SE, Gitschier J. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia a. Nat Genet. 1993;5(3):236–41.
van Galen KPM, Engelen ET, Mauser-Bunschoten EP, van Es RJJ, Schutgens REG. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. Cochrane Database Syst Rev. 2015;12:CD011385.
Yilmaz D, Akin M, Ay Y, Balkan C, ÇElik A, ErgÜN O, et al. A single centre experience in circumcision of haemophilia patients: Izmir protocol. Haemophilia. 2010;16(6):888–91.
Pipe SW, Kessler CM. Evidence-based guidelines support integrated disease management as the optimal model of haemophilia care. Haemophilia. 2016;22:3–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Saini, S., Dunn, A.L. (2020). Management of an Infant with Hemophilia A. In: Dunn, A., Kerlin, B., O'Brien, S., Rose, M., Kumar, R. (eds) Pediatric Bleeding Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-31661-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-31661-7_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-31660-0
Online ISBN: 978-3-030-31661-7
eBook Packages: MedicineMedicine (R0)